These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33420706)

  • 1. Progression of neuropsychiatric symptoms in young-onset versus late-onset Alzheimer's disease.
    Gumus M; Multani N; Mack ML; Tartaglia MC;
    Geroscience; 2021 Feb; 43(1):213-223. PubMed ID: 33420706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subscale validation of the neuropsychiatric inventory questionnaire: comparison of Alzheimer's disease neuroimaging initiative and national Alzheimer's coordinating center cohorts.
    Trzepacz PT; Saykin A; Yu P; Bhamditipati P; Sun J; Dennehy EB; Willis B; Cummings JL;
    Am J Geriatr Psychiatry; 2013 Jul; 21(7):607-22. PubMed ID: 23602309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The severity of neuropsychiatric symptoms is higher in early-onset than late-onset Alzheimer's disease.
    Falgàs N; Allen IE; Spina S; Grant H; Piña Escudero SD; Merrilees J; Gearhart R; Rosen HJ; Kramer JH; Seeley WW; Neylan TC; Miller BL; Rabinovici GD; Grinberg LT; Walsh CM
    Eur J Neurol; 2022 Apr; 29(4):957-967. PubMed ID: 34862834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychiatric Profile in Early Versus Late Onset Alzheimer's Disease.
    Ferreira MDC; Abreu MJ; Machado C; Santos B; Machado Á; Costa AS
    Am J Alzheimers Dis Other Demen; 2018 Mar; 33(2):93-99. PubMed ID: 29210282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of neuropsychiatric symptoms in young-onset compared to late-onset Alzheimer's disease - part 1: findings of the two-year longitudinal NeedYD-study.
    van Vliet D; de Vugt ME; Aalten P; Bakker C; Pijnenburg YA; Vernooij-Dassen MJ; Koopmans RT; Verhey FR
    Dement Geriatr Cogn Disord; 2012; 34(5-6):319-27. PubMed ID: 23208452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and Severity of Neuropsychiatric Symptoms in Early- Versus Late-Onset Alzheimer's Disease.
    Baillon S; Gasper A; Wilson-Morkeh F; Pritchard M; Jesu A; Velayudhan L
    Am J Alzheimers Dis Other Demen; 2019; 34(7-8):433-438. PubMed ID: 30935215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Network analysis of neuropsychiatric symptoms in Alzheimer's disease.
    Goodwin GJ; Moeller S; Nguyen A; Cummings JL; John SE
    Alzheimers Res Ther; 2023 Aug; 15(1):135. PubMed ID: 37568209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia.
    Siafarikas N; Alnæs D; Monereo-Sanchez J; Lund MJ; Selbaek G; Stylianou-Korsnes M; Persson K; Barca ML; Almdahl IS; Fladby T; Aarsland D; Andreassen OA; Westlye LT
    Int Psychogeriatr; 2021 Nov; 33(11):1217-1228. PubMed ID: 34399870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychiatric symptoms in limbic-predominant age-related TDP-43 encephalopathy and Alzheimer's disease.
    Liu KY; Reeves S; McAleese KE; Attems J; Francis P; Thomas A; Howard R
    Brain; 2020 Dec; 143(12):3842-3849. PubMed ID: 33188391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of neuropsychiatric symptoms in Alzheimer's disease: a cross-sectional descriptive study in Thailand.
    Charernboon T; Phanasathit M
    J Med Assoc Thai; 2014 May; 97(5):560-5. PubMed ID: 25065098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer's disease.
    Ng KP; Pascoal TA; Mathotaarachchi S; Chan YH; Jiang L; Therriault J; Benedet AL; Shin M; Kandiah N; Greenwood CMT; Rosa-Neto P; Gauthier S;
    Transl Neurodegener; 2021 Jan; 10(1):1. PubMed ID: 33390174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comparison of Behavioral and Psychological Symptoms of Dementia (BPSD) and BPSD Sub-Syndromes in Early-Onset and Late-Onset Alzheimer's Disease.
    Altomari N; Bruno F; Laganà V; Smirne N; Colao R; Curcio S; Di Lorenzo R; Frangipane F; Maletta R; Puccio G; Bruni AC
    J Alzheimers Dis; 2022; 85(2):691-699. PubMed ID: 34864668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease, and its relationship with cognitive impairment.
    M FM; Molano A; Castro J; Zarranz JJ
    Curr Alzheimer Res; 2010 Sep; 7(6):517-26. PubMed ID: 20455862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of brain amyloidosis with the incidence and frequency of neuropsychiatric symptoms in ADNI: a multisite observational cohort study.
    Goukasian N; Hwang KS; Romero T; Grotts J; Do TM; Groh JR; Bateman DR; Apostolova LG
    BMJ Open; 2019 Dec; 9(12):e031947. PubMed ID: 31857304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persisting neuropsychiatric symptoms, Alzheimer's disease, and cerebrospinal fluid cortisol and dehydroepiandrosterone sulfate.
    Ouanes S; Rabl M; Clark C; Kirschbaum C; Popp J
    Alzheimers Res Ther; 2022 Dec; 14(1):190. PubMed ID: 36529757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early behavioural changes in familial Alzheimer's disease in the Dominantly Inherited Alzheimer Network.
    Ringman JM; Liang LJ; Zhou Y; Vangala S; Teng E; Kremen S; Wharton D; Goate A; Marcus DS; Farlow M; Ghetti B; McDade E; Masters CL; Mayeux RP; Rossor M; Salloway S; Schofield PR; Cummings JL; Buckles V; Bateman R; Morris JC;
    Brain; 2015 Apr; 138(Pt 4):1036-45. PubMed ID: 25688083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychotropic Medication and Cognitive, Functional, and Neuropsychiatric Outcomes in Alzheimer's Disease (AD).
    Oh ES; Rosenberg PB; Rattinger GB; Stuart EA; Lyketsos CG; Leoutsakos JS
    J Am Geriatr Soc; 2021 Apr; 69(4):955-963. PubMed ID: 33382921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Phosphorylated Tau at Threonine 181 and Neuropsychiatric Symptoms in Preclinical and Prodromal Alzheimer Disease.
    Ghahremani M; Wang M; Chen HY; Zetterberg H; Smith E; Ismail Z;
    Neurology; 2023 Feb; 100(7):e683-e693. PubMed ID: 36323521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease.
    Panza F; Frisardi V; Seripa D; D'Onofrio G; Santamato A; Masullo C; Logroscino G; Solfrizzi V; Pilotto A
    Ageing Res Rev; 2012 Jan; 11(1):87-103. PubMed ID: 21763789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depressive, functional status, and neuropsychiatric symptom trajectories before an Alzheimer's disease diagnosis.
    Gaugler JE; Hovater M; Roth DL; Johnston JA; Kane RL; Sarsour K
    Aging Ment Health; 2014; 18(1):110-6. PubMed ID: 23822174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.